Document Detail


Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
MedLine Citation:
PMID:  19820404     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Conflicting data have been reported in the literature about the role of retinol-binding protein 4 (RBP4) in insulin sensitivity, type 2 diabetes, and obesity in humans. It is of interest whether serum RBP4 is associated with various features of nonalcoholic fatty liver disease (NAFLD). METHODS: Serum RBP4, adiponectin, leptin, and resistin were measured by enzyme-linked immunosorbent assay in 76 nondiabetic NAFLD patients, 55 of whom had elevated alanine aminotransferase (ALT). Thirty-four of 55 underwent a liver biopsy. Fasting insulin, liver and lipid panels were analyzed and ultrasound score, body mass index, and homeostasis model assessment for insulin resistance were recorded for each patient. Twenty-four healthy individuals served as controls. RESULTS: Serum RBP4 levels were not different between the steatosis group and controls as well as between the groups with high and normal ALT. Serum adiponectin was significantly lower and resistin was higher (P<0.001) in steatosis group compared with controls. RBP4 and resistin were negatively correlated, whereas leptin and resistin were correlated positively in patients with high ALT. At multivariate analysis, homeostasis model assessment for insulin resistance [odds ratio (OR): 10.71; 95% confidence interval (95% CI): 1.40-81.74], leptin (OR: 22.14; 95% CI: 2.40-204.12), resistin (OR: 6.29; 95% CI: 0.94-41.91), ALT (OR: 1.205; 95% CI: 1.05-1.39), and aspartate aminotransferase (OR: 0.846; 95% CI: 0.72-0.99) were independent variables associated with steatosis. Serum leptin, adiponectin, resistin, gamma-glutamyl transferase, and cholesterol were associated with histological activity by multivariate linear regression. CONCLUSION: Serum RBP4 is not a predictive factor in NAFLD irrespective of ALT. Low adiponectin, elevated resistin, and leptin were significantly associated with necroinflammation.
Authors:
Cem Cengiz; Yasemin Ardicoglu; Safak Bulut; Sedat Boyacioglu
Related Documents :
16081264 - Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and p...
16556684 - Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipid...
12514304 - The conjugated linoleic acid (cla) isomer, t10c12-cla, is inversely associated with cha...
18846024 - Acute effects of orlistat on postprandial serum leptin levels in nondiabetic obese pati...
8373434 - Modification of the glyoxalase system in streptozotocin-induced diabetic rats. effect o...
16081264 - Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and p...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of gastroenterology & hepatology     Volume:  22     ISSN:  1473-5687     ISO Abbreviation:  Eur J Gastroenterol Hepatol     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-10     Completed Date:  2010-09-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9000874     Medline TA:  Eur J Gastroenterol Hepatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  813-9     Citation Subset:  IM    
Affiliation:
Department of Gastroenterology, Mesa Hospital, Ankara, Turkey. cemcengizmd@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adiponectin / blood
Adult
Alanine Transaminase / blood
Aspartate Aminotransferases / blood
Biological Markers / blood
Cholesterol / blood
Cohort Studies
Fatty Liver / blood*,  pathology*,  ultrasonography
Female
Humans
Insulin / blood
Insulin Resistance / physiology
Leptin / blood
Male
Middle Aged
Prospective Studies
Resistin / blood
Retinol-Binding Proteins, Plasma / analysis*
gamma-Glutamyltransferase / blood
Chemical
Reg. No./Substance:
0/Adiponectin; 0/Biological Markers; 0/Leptin; 0/RBP4 protein, human; 0/Resistin; 0/Retinol-Binding Proteins, Plasma; 11061-68-0/Insulin; 57-88-5/Cholesterol; EC 2.3.2.2/gamma-Glutamyltransferase; EC 2.6.1.1/Aspartate Aminotransferases; EC 2.6.1.2/Alanine Transaminase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Well appearing young infants with fever without known source in the emergency department: are lumbar...
Next Document:  Estimation of clonazepam abuse liability: a new method using a reimbursed drug database.